Listening Session: Optimizing the Food and Drug Administration's Use of and Processes for Advisory Committees; Public Meeting; Request for Comments

Issuing agencies

Abstract

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following virtual public meeting entitled "Listening Session: Optimizing FDA's Use of and Processes for Advisory Committees." The purpose of the listening session is to solicit feedback on the Agency's use of and processes for its advisory committee system.